New Notices
- New General Announcement: Polyethylene Glycol (posted 07-Oct-2024)
- New Notice of Intent to Revise: Garcinia Family of Dietary Ingredient Monographs (posted 01-Oct-2024; input deadline 31-Oct-2024)
- New Notice of Intent to Revise: <621> Chromatography (posted 27-Sep-2024)
- New Notice of Intent to Revise: Ioversol Injection (posted 27-Sep-2024)
- New Notice of Intent to Revise: Tamsulosin Hydrochloride Capsules (posted 27-Sep-2024)
- New General Chapter Prospectus: <1221> Ongoing Procedure Performance Verification (posted 27-Sep-2024; input deadline 27-Oct-2024)
- New Publication Announcement: Update on Official Date for Xanthan Gum (posted 27-Sep-2024)
- New Notice of Intent to Revise: Desvenlafaxine Succinate (posted 30-Aug-2024)
- New Notice of Intent to Revise: Xylazine (posted 30-Aug-2024)
- New Notice of Intent to Revise: Xylazine Hydrochloride (posted 30-Aug-2024)
- New Notice of Intent to Revise: Xylazine Injection (posted 30-Aug-2024)
- New General Chapter Prospectus: <320> NMR Spectroscopy for Determination of Degree of Hydrolysis for Polyvinyl Alcohol and Vinyl Alcohol Homopolymer, and Monomer Ratio for Vinyl Alcohol and Vinyl Acetate Copolymer (posted 30-Aug-2024; input deadline 29-Sep-2024)
- New General Announcement: Analytical Procedures for Quality of mRNA Vaccines and Therapeutics (Draft Guidelines: 3rd Edition) (posted 02-Aug-2024; input deadline 31-Oct-2024)
- New Notice of Intent to Revise: Sodium Polystyrene Sulfonate Suspension (posted 26-Jul-2024)